Abu Dhabi researchers hopeful of Type 1 diabetes breakthrough within two years
Researchers at the Abu Dhabi Stem Cells Centre are hopeful of a breakthrough in their work on a cure for Type 1 diabetes 'in the next couple of years'. The most promising development is focused on regenerating the pancreas using stem cells and is part of a collaboration with Kyoto University and research company Rege Nephro. In Type 1 diabetes, the pancreas progressively reduces the amount of insulin (the hormone that regulates blood glucose levels) it produces until it stops producing any at all. If glucose in the blood is too high, it can seriously damage the body's organs. It is hoped pancreas regeneration can reverse this process. 'We're very optimistic that in the next couple of years, we'll have something solid to offer patients,' Prof Yendry Ventura, the centre's chief executive, said. 'This isn't just stem cell therapy – it's an approach to regenerate the pancreas itself using a specific type of engineered cell.' The process is still in the pre-clinical stage but hopes remain high. Research and development 'takes time', Prof Ventura added. 'You need to stabilise a strong cell line, trial it in the lab, test it on animals and only then can you move into human trials. Right now, we're preparing to begin animal testing, after extensive lab work with our Japanese partners.' The work is being showcased at Expo 2025 in Osaka, Japan. The fair provides an opportunity to highlight the centre's scientific achievements and the UAE's growing presence in cutting-edge health care, Prof Ventura said. 'We're using Osaka Expo as a platform to present the progress we've made with our partners Kyoto University and [biotech firm] Rege Nephro,' he added. 'It's also a chance to showcase what we've built in Abu Dhabi and how we're working alongside some of the world's most respected institutions.' Though ADSCC has collaborative relationships, it handles its own cell production and storage. 'We have our own infrastructure. Cells intended for therapies need special storage conditions,' Prof Ventura said. 'There's a difference between storing tissue for studies and storing it for treatment purposes.' He said the UAE's capabilities complement those of its international partners. 'We're focused on developing specific stem cells that can later become any kind of tissue. That's different from just storing samples, but the two approaches work hand in hand.' The project is being developed in close co-operation with Kyoto University's Centre for iPS Cell Research and Application. 'Their contribution has given us access to expertise and speed,' said Prof Ventura. 'At the same time, the UAE is emerging as a leader in stem cell research across the region.' ADSCC is not new to breakthroughs in this area. In January, the centre announced the successful treatment of a 20-year-old Emirati patient with Type 1 diabetes, using umbilical cord-derived mesenchymal stem cells. The procedure, developed and carried out entirely at ADSCC, resulted in significantly improved blood sugar levels and a drop in diabetes-related antibodies within one month of treatment. The treatment is a major step forward in using regenerative medicine to manage diabetes. Regenerative medicine focuses on the body's ability to heal itself at cellular and organ levels. It includes treatments that use stem cells, engineered tissues and even bio-manufactured organs to restore or replace damaged parts of the body. Mesenchymal stem cells, known for their ability to modulate immune responses and repair tissue, are gaining attention as a possible way to restore pancreatic function and reduce complications in diabetic patients. 'Being able to do this entirely in the UAE, using cells produced locally, is a milestone for us,' Prof Ventura said. The country's participation at the expo in Japan reflects a broader national commitment to innovation in health care, said Dr Fatima Al Kaabi, executive director of the Abu Dhabi Bone Marrow Transplant Programme. 'We're a young centre, only six years since inception, but we're already standing alongside global leaders,' she said. 'It's an honour to represent the UAE and show our standards meet the highest benchmarks.' She highlighted the power of pluripotent stem cells, which have the ability to turn into almost any type of tissue. 'Whether it's heart, liver, brain or pancreas, these cells hold incredible potential. The challenge now is to harness that potential and find real solutions to some of the world's most devastating diseases.' Dr Al Kaabi said regenerative medicine is not only the future of health care, it's already reshaping how doctors approach treatment. 'If we can unlock what these cells can do, we can transform the way we treat cancer, autoimmune conditions and traumatic injuries. With the vision and talent we have at ADSCC, I believe we're on the right path.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
2 hours ago
- Khaleej Times
'More than ceremony': UAE minister honours 50 people of determination upon graduating
Fifty young men and women with disabilities walked proudly across the stage in Ajman, celebrating a moment many thought might never come - they were graduating. The Ministry of Family held a special ceremony at the Cultural Centre in Ajman to honour 50 students, all of whom completed training at disability care and rehabilitation centres across the UAE. The graduates came from Dubai, Ajman, Ras Al Khaimah, Fujairah, and Dibba Fujairah. For the first time, they were joined by students from the 'Mashaghel Rehabilitation Centres' vocational training programme, creating a shared celebration of hard work and progress. Sana Suhail, Minister of Family, honoured each graduate personally. These students had taken a path that required strength, not just physically, but emotionally. Through their academic and professional training, they showed that disabilities do not stop dreams. Their journey has become an example for many others. She praised the graduates for their determination and commitment. She emphasised that this achievement stands as a testament to their unwavering will and the profound positive impact of these programmes, which aim to build a more inclusive and equitable society. 'The event was more than a ceremony. It was a sign of what's possible when people of determination are given support and encouragement. It showed the importance of believing in their abilities and creating spaces where they can learn, grow, and contribute,' she said. The ceremony was a celebration and reinforcement of inclusion and empowerment. It highlighted the importance of investing in the capabilities of people of determination and providing a supportive environment for them to contribute effectively to the nation's development. It also showcases the Ministry of Family's important work in promoting social inclusion and ensuring equal access to education, healthcare, and jobs for people of determination, in line with the National Policy for Empowering Persons with Disabilities. The Ministry of Family operates several rehabilitation centres for people of determination across different emirates, including Dubai, Ajman, Umm Al Quwain, Ras Al Khaimah, and Dibba Al-Fujairah. These centres work with individuals aged 4 to 18, offering customised education and training. Once students complete the programme, they can move into vocational work, take on small projects, or prepare to enter the job market. One programme, called the 'Mashaghel Rehabilitation Centres Programme,' gives people of determination training in entrepreneurship and home-based business skills. It helps them work towards independence and learn how to run their own small projects or businesses from home.
The National
4 hours ago
- The National
UAE evacuates critically injured child from Gaza for hospital treatment
A three-year-old boy seriously injured in an air strike on Gaza is on the road to recovery after receiving urgent treatment in the UAE. Hatim Awad suffered major injuries, including second and third-degree burns to his body, in an Israeli attack on the enclave. The strike killed his entire family. Hatim was evacuated under the UAE's Operation Chivalrous Knight 3 initiative, a humanitarian mission launched last year under the directive of President Sheikh Mohamed. The child arrived at Sheikh Shakhbout Medical City in Abu Dhabi on June 12 to begin comprehensive treatment, Dr Abdulqader Almessabi, chief medical officer at the hospital, said in a report by state news agency Wam. Dr Almessabi added that Hatim's condition has since improved significantly. His evacuation was co-ordinated with other authorities to ensure his safety throughout the journey to the hospital.
TECHx
6 hours ago
- TECHx
Abu Dhabi, Abbott Partner to Boost Local Pharma Sector
Home » Smart Sectors » Healthcare » Abu Dhabi, Abbott Partner to Boost Local Pharma Sector The Department of Health, Abu Dhabi (DoH), the healthcare sector regulator in Abu Dhabi, announced a strategic partnership with global healthcare leader Abbott. The agreement was signed during the BIO International Convention held in Boston, USA. The partnership aims to localise pharmaceutical manufacturing in Abu Dhabi. It also focuses on advancing digital health solutions across the emirate. Officials revealed that the collaboration builds on Abu Dhabi's advanced life sciences infrastructure. This move supports the emirate's goal to reduce dependency on imports and strengthen supply chain resilience. It further reflects Abu Dhabi's commitment to fostering a self-sufficient and sustainable healthcare ecosystem. Dr. Noura Al Ghaithi, Undersecretary of DoH, stated that the partnership follows the recent launch of the Health, Endurance, Longevity and Medicine (HELM) Cluster in Abu Dhabi. She added that the emirate is equipped with an integrated infrastructure to support local manufacturing and R&D. She said the agreement would position Abu Dhabi as a regional healthcare hub and leader in life sciences. According to her, aligning DoH's strategic vision with Abbott's global expertise will accelerate the delivery of innovative healthcare products and solutions. The collaboration is built around four key pillars: Localising Abbott's pharmaceutical portfolio and developing biosimilars. Advancing digital transformation through electronic patient information leaflets. Launching education programs to strengthen the healthcare workforce. Supporting regulatory alignment and joint R&D initiatives. Mazen Bachir, Regional Director for Abbott's established pharmaceuticals business in the Gulf, Emerging Markets and Levant, reported that this partnership will enhance healthcare resilience and innovation in Abu Dhabi. He highlighted Abbott's ongoing commitment to the UAE's healthcare system. He noted that the partnership will also include digitising life sciences product information and launching training initiatives to build local capabilities. In addition, both parties will explore opportunities for joint research and development. DoH also reported that a high-level delegation has embarked on a strategic mission to the United States from 15 to 21 June 2025. The delegation will conduct over 20 meetings with public and private sector leaders. These meetings aim to promote knowledge exchange, attract investments, and sign new agreements that accelerate advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes: Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, and PureHealth. Etihad Cargo, New York University Abu Dhabi, Khalifa University, startAD, and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI). This announcement highlights Abu Dhabi's global ambitions in life sciences and healthcare innovation.
